Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$201.05 - $221.7 $25.4 Million - $28 Million
-126,443 Reduced 23.18%
418,995 $84.2 Million
Q2 2023

Aug 10, 2023

BUY
$211.93 - $241.33 $782,869 - $891,473
3,694 Added 0.68%
545,438 $132 Million
Q1 2023

May 09, 2023

BUY
$213.32 - $257.83 $24.8 Million - $29.9 Million
116,029 Added 27.26%
541,744 $124 Million
Q4 2022

Feb 07, 2023

BUY
$203.72 - $248.97 $1.48 Million - $1.81 Million
7,275 Added 1.74%
425,715 $100 Million
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $5.18 Million - $6.63 Million
25,298 Added 6.43%
418,440 $85.7 Million
Q2 2022

Aug 10, 2022

BUY
$213.86 - $277.87 $1.37 Million - $1.78 Million
6,406 Added 1.66%
393,142 $92.2 Million
Q1 2022

May 10, 2022

BUY
$259.82 - $298.18 $2.53 Million - $2.91 Million
9,747 Added 2.59%
386,736 $102 Million
Q4 2021

Feb 04, 2022

SELL
$271.6 - $314.21 $802,306 - $928,176
-2,954 Reduced 0.78%
376,989 $118 Million
Q3 2021

Nov 05, 2021

BUY
$274.82 - $308.34 $2.93 Million - $3.28 Million
10,649 Added 2.88%
379,943 $107 Million
Q2 2021

Aug 12, 2021

SELL
$251.87 - $278.14 $69.7 Million - $77 Million
-276,841 Reduced 42.85%
369,294 $102 Million
Q1 2021

May 10, 2021

SELL
$204.88 - $255.03 $3.83 Million - $4.77 Million
-18,692 Reduced 2.81%
646,135 $165 Million
Q4 2020

Feb 04, 2021

SELL
$186.91 - $214.42 $102 Million - $117 Million
-544,174 Reduced 45.01%
664,827 $135 Million
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $53.1 Million - $64 Million
-317,750 Reduced 20.81%
1,209,001 $228 Million
Q2 2020

Aug 12, 2020

SELL
$113.31 - $182.44 $7.68 Million - $12.4 Million
-67,819 Reduced 4.25%
1,526,751 $254 Million
Q1 2020

May 13, 2020

BUY
$104.32 - $195.28 $3.53 Million - $6.61 Million
33,837 Added 2.17%
1,594,570 $201 Million
Q4 2019

Feb 05, 2020

SELL
$163.48 - $173.61 $14.2 Million - $15.1 Million
-86,861 Reduced 5.27%
1,560,733 $264 Million
Q3 2019

Nov 20, 2019

SELL
$159.77 - $178.1 $126 Million - $140 Million
-785,828 Reduced 32.29%
1,647,594 $277 Million
Q3 2019

Nov 08, 2019

SELL
$159.77 - $178.1 $451,510 - $503,310
-2,826 Reduced 0.12%
2,433,422 $421 Million
Q2 2019

Aug 26, 2019

SELL
$144.16 - $172.9 $6,343 - $7,607
-44 Reduced -0.0%
2,436,248 $421 Million
Q2 2019

Aug 09, 2019

SELL
$144.16 - $172.9 $43.4 Million - $52 Million
-300,781 Reduced 10.99%
2,436,292 $421 Million
Q1 2019

May 03, 2019

SELL
$123.7 - $156.3 $65.8 Million - $83.2 Million
-532,195 Reduced 16.28%
2,737,073 $419 Million
Q4 2018

Feb 07, 2019

SELL
$120.82 - $174.09 $144 Million - $208 Million
-1,195,806 Reduced 26.78%
3,269,268 $413 Million
Q3 2018

Nov 14, 2018

SELL
$167.67 - $188.27 $202 Million - $226 Million
-1,202,818 Reduced 21.22%
4,465,074 $775 Million
Q2 2018

Aug 03, 2018

SELL
$160.33 - $189.41 $941,938 - $1.11 Million
-5,875 Reduced 0.1%
5,667,892 $1.02 Billion
Q1 2018

May 04, 2018

BUY
$161.53 - $178.11 $66.2 Million - $73 Million
409,742 Added 7.78%
5,673,767 $918 Million
Q4 2017

Feb 01, 2018

BUY
$147.99 - $163.95 $95.4 Million - $106 Million
644,355 Added 13.95%
5,264,025 $840 Million
Q3 2017

Nov 02, 2017

BUY
$149.47 - $160.56 $691 Million - $742 Million
4,619,670
4,619,670 $697 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.